Precision and Personalized Medicine
Novel CSF biomarkers signal new avenues for Parkinson’s therapeutics
A new study identifies a novel cerebrospinal fluid biomarker for Parkinson’s disease, expanding the scope of possible drug targets.
3D printing in drug manufacturing: unlocking future possibilities
Approach to spur testosterone production instead of synthesis on the horizon
ICON Q&A: talking affordability in cell and gene therapies
The reality of optimising real-world data
Adaptimmune Q&A: an alternative approach to T-cell cancer therapies
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
